Versiti
Versiti is a nonprofit, 501(c)(3) blood health organization dedicated to improving patient lives and supporting healthcare partners through blood donation, innovative research, and advanced diagnostic testing. With locations across the Midwest, Versiti is a leader in blood health innovation, organ and tissue donation, and precision medicine. The organization is committed to enhancing patient care, advancing healthcare standards, and fostering a vibrant donor community. Versiti also supports education through scholarships and is recognized for its compliance and accreditations.
Industries
Nr. of Employees
Very Large (1000+)
Products
ABO and Rh serological test
Standard serological test for ABO and Rh blood group determination to support pretransfusion compatibility and diagnosis.
Antibody identification and immunohematology workup
Tiered immunohematology workflow including serological panels, direct antiglobulin testing and selected cell panels for antibody identification and hemolytic anemia workup.
Autosomal dominant thrombocytopenia genetic panel (NGS/aCGH)
Genetic panel to detect germline variants associated with inherited thrombocytopenias, available as NGS, aCGH, concurrent or reflex workflows; includes CNV analysis and confirmatory sequencing where applicable.
C/c genotyping (allele-specific PCR)
Genotyping for Rh C and c antigens using allele-specific PCR for fetal and parental samples to support fetal red cell antigen assessment.
ADAMTS13 inhibitor assay (FRET-based kinetic)
Assay measuring inhibitory antibodies to ADAMTS13 using a fluorescence resonance energy transfer (FRET)-based kinetic method for evaluation of thrombotic thrombocytopenic purpura.
Bernard–Soulier syndrome genetic panel (NGS/aCGH)
Targeted genetic panel for detection of germline variants in genes associated with Bernard–Soulier syndrome, available as NGS, aCGH, concurrent or reflex workflows.
ABO and Rh serological test
Standard serological test for ABO and Rh blood group determination to support pretransfusion compatibility and diagnosis.
Antibody identification and immunohematology workup
Tiered immunohematology workflow including serological panels, direct antiglobulin testing and selected cell panels for antibody identification and hemolytic anemia workup.
Autosomal dominant thrombocytopenia genetic panel (NGS/aCGH)
Genetic panel to detect germline variants associated with inherited thrombocytopenias, available as NGS, aCGH, concurrent or reflex workflows; includes CNV analysis and confirmatory sequencing where applicable.
C/c genotyping (allele-specific PCR)
Genotyping for Rh C and c antigens using allele-specific PCR for fetal and parental samples to support fetal red cell antigen assessment.
ADAMTS13 inhibitor assay (FRET-based kinetic)
Assay measuring inhibitory antibodies to ADAMTS13 using a fluorescence resonance energy transfer (FRET)-based kinetic method for evaluation of thrombotic thrombocytopenic purpura.
Bernard–Soulier syndrome genetic panel (NGS/aCGH)
Targeted genetic panel for detection of germline variants in genes associated with Bernard–Soulier syndrome, available as NGS, aCGH, concurrent or reflex workflows.
Expertise Areas
- Transfusion medicine and blood banking
- Immunohematology and serological problem resolution
- Hematology genetics and molecular diagnostics
- Histocompatibility and HLA testing
Key Technologies
- Next-generation sequencing (NGS)
- Array comparative genomic hybridization (aCGH)
- PCR and bi-directional Sanger sequencing
- Allele-specific PCR
Key People
Chief of Staff
EVP and Chief Human Resources Officer
VP and Chief Quality Officer
VP of Versiti Organ and Tissue
EVP Medical Sciences Institute and Chief Medical Officer
EVP and Chief Laboratory Officer
Chief of Staff
EVP and Chief Human Resources Officer
VP and Chief Quality Officer
VP of Versiti Organ and Tissue
EVP Medical Sciences Institute and Chief Medical Officer
EVP and Chief Laboratory Officer
News & Updates
Jessica Drouillard, VP and Chief Quality Officer, was among the first in the nation to earn the CABP credential from the Association for the Advancement of Blood & Biotherapies (AABB) in 2022.
Jessica Drouillard, VP and Chief Quality Officer, was among the first in the nation to earn the CABP credential from the Association for the Advancement of Blood & Biotherapies (AABB) in 2022.